Soleno Therapeutics Inc

NASDAQ:SLNO  
0.59
-0.03 (-4.48%)
Earnings Announcements

Soleno Therapeutics Reports Q3 2021 Financial Results

Published: 11/10/2021 22:45 GMT
Soleno Therapeutics Inc (SLNO) - Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.35.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.